½ÃÀ庸°í¼­
»óǰÄÚµå
1262948

¼¼°èÀÇ µ¿¹° ÀǾàǰ ½ÃÀå ¸®Æ÷Æ®(2023³â)

Veterinary Medicine Global Market Report 2023

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

µ¿¹° ÀǾàǰ ¼¼°è ½ÃÀåÀº 2022³â 269¾ï 4,000¸¸ ´Þ·¯¿¡¼­ 2023³â¿¡´Â 288¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇϰí, CAGR 7.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ·¯½Ã¾Æ ¿ìÅ©¶óÀ̳ª ÀüÀïÀº Àû¾îµµ ´Ü±âÀûÀ¸·Î COVID-19 ÆÒµ¥¹ÍÀÇ ¼¼°è °æÁ¦ ȸº¹ÀÇ °¡´É¼ºÀ» È¥¶õ½ÃÄ×½À´Ï´Ù. ÀÌ µÎ ±¹°¡ °£ÀÇ ÀüÀïÀº ¿©·¯ ±¹°¡¿¡ ´ëÇÑ °æÁ¦ Á¦Àç, »óǰ °¡°Ý »ó½Â, °ø±Þ¸Á È¥¶õÀ¸·Î À̾îÁ³À¸¸ç, »óǰ°ú ¼­ºñ½º Àü¹Ý¿¡ ÀÎÇ÷¹À̼ÇÀ» ÀÏÀ¸ÄÑ ¼¼°è ¸¹Àº ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. µ¿¹° ÀǾàǰ ½ÃÀåÀº 2027³â¿¡´Â CAGR 6.5%·Î 370¾ï 8,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

2022³â µ¿¹° ÀǾàǰ ½ÃÀå¿¡¼­´Â ºÏ¹Ì°¡ ÃÖ´ë Áö¿ªÀÌ µÇ¾ú½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀÌ µÉ Àü¸ÁÀÔ´Ï´Ù. µ¿¹° ÀǾàǰ ½ÃÀå º¸°í¼­ÀÇ ´ë»ó Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ¼­À¯·´, Áßµ¿ À¯·´, ºÏ¹Ì, ³²¹Ì, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù.

¹Ý·Áµ¿¹° ¼ÒÀ¯ÀÚ Áõ°¡´Â µ¿¹° ÀǾàǰ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ý·Áµ¿¹° ¼ÒÀ¯ÀÚ´Â ¹Ý·Áµ¿¹°À» ¼ÒÀ¯Çϰųª ÀÔ¾çÇÏ´Â °³ÀÎÀ» ÀǹÌÇÕ´Ï´Ù. ¹Ý·Áµ¿¹° ¼ÒÀ¯ÀÚ´Â ¹Ý·Áµ¿¹°°ú ±×µéÀÇ °Ç°­¿¡ ½Å°æ ¾²°í ÀÖ½À´Ï´Ù. µû¶ó¼­ ¹Ý·Áµ¿¹°¿¡ ÇÊ¿äÇÑ °Ç°­½Ã¼³À» Á¦°øÇÏ¿© µ¿¹° ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ³ôÀÌ°í µ¿¹° ÀǾàǰ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â µ¿¹°ÇÐ´ë ¿¹¹æ¿¡ Á¾»çÇÏ´Â ¹Ì±¹ÀÇ ºñ¿µ¸®´Üü The American Society for the Prevention of Cruelty to Animals(ASPCA)ÀÇ Àü±¹ ¿©·ÐÁ¶»ç¿¡ µû¸£¸é ÀÀ´äÀÚ Áß 5¼¼´ë¿¡ 1¼¼´ë°¡ °í¾çÀÌ ¶Ç´Â °³ ¸¦ ±â¸£°í ÀÖ¾î 2,300¸¸ °¡±¸¸¦ Â÷ÁöÇÏ´Â COVID-19 À§±â°¡ ½ÃÀÛµÇ°í ³ª¼­. °³ÀÇ 90%, °í¾çÀÌÀÇ 85%´Â ¿©ÀüÈ÷ ¸¶À» ºÎ¸ðÀÇ Áý¿¡ ÀÖ°í, °¡Á¤Àº ´Ù½Ã ¹ö¸®Áö ¾ÊÀ» °ÍÀÔ´Ï´Ù. ÀÌ¿Í °°ÀÌ ¹Ý·Áµ¿¹°ÀÇ »çÀ°ÀÚ ¼ö Áõ°¡°¡ µ¿¹° ÀǾàǰ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå µ¿¹° ÀǾàǰ ½ÃÀå Æ¯Â¡

Á¦3Àå µ¿¹° ÀǾàǰ ½ÃÀåÀÇ µ¿Çâ°ú Àü·«

Á¦4Àå µ¿¹° ÀǾàǰ ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

  • COVID-19°¡ µ¿¹° ÀǾàǰ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • ¿ìÅ©¶óÀ̳ª¿Í ·¯½Ã¾ÆÀÇ ÀüÀïÀÌ µ¿¹° ÀǾàǰ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • °íÀÎÇ÷¹À̼ÇÀÌ µ¿¹° ÀǾàǰ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå µ¿¹° ÀǾàǰ ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

  • ¼¼°è µ¿¹° ÀǾàǰ ½ÃÀå ½ÇÀû, 2017-2022³â
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¼¼°è µ¿¹° ÀǾàǰ ½ÃÀå ¿¹Ãø, 2022-2027F, 2032F
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

Á¦6Àå µ¿¹° ÀǾàǰ ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°è µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾à¹°
  • ¹é½Å
  • ÀÇ·á¿ë »ç·á ÷°¡¹°
  • ¼¼°è µ¿¹° ÀǾàǰ ½ÃÀå, µ¿¹° Á¾·ùº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¹Ý·Áµ¿¹°
  • °¡Ãà
  • ¼¼°è µ¿¹° ÀǾàǰ ½ÃÀå, Åõ¿© °æ·Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • °æ±¸ °æ·Î
  • ºÎ¸ðÀÇ ·çÆ®
  • ±¹¼Ò°æ·Î
  • ¼¼°è µ¿¹° ÀǾàǰ ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¿¹°º´¿ø ¾à±¹
  • ¼Ò¸Åµ¿¹°¿ë ¾à±¹
  • ¼¼°è µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ·¹ÆÛ·±½º ½ÇÇè½Ç
  • Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»ç/¿ø³» °Ë»ç
  • µ¿¹°º´¿ø ¹× Áø·á¼Ò
  • ±âŸ ÃÖÁ¾ »ç¿ëÀÚ

Á¦7Àå µ¿¹° ÀǾàǰ ½ÃÀåÀÇ Áö¿ª ¹× ±¹°¡ ºÐ¼®

  • ¼¼°è µ¿¹° ÀǾàǰ ½ÃÀå, Áö¿ªº°, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼¼°è µ¿¹° ÀǾàǰ ½ÃÀå, ±¹°¡º°, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç µ¿¹° ÀǾàǰ ½ÃÀå

  • ¾Æ½Ã¾ÆÅÂÆò¾ç µ¿¹° ÀǾàǰ ½ÃÀå °³¿ä
  • Áö¿ª Á¤º¸, COVID-19ÀÇ ¿µÇâ, ½ÃÀå Á¤º¸, ¹è°æ Á¤º¸, Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê, ±ÔÁ¦, ±ÔÁ¦ ±â°ü, ÁÖ¿ä ´Üü, °ú¼¼µÇ´Â ¼¼±Ý, ¹ýÀμ¼ ±¸Á¶, ÅõÀÚ, ÁÖ¿ä ±â¾÷
  • ¾Æ½Ã¾ÆÅÂÆò¾ç µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾Æ½Ã¾ÆÅÂÆò¾ç µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦9Àå Áß±¹ µ¿¹° ÀǾàǰ ½ÃÀå

  • Áß±¹ µ¿¹° ÀǾàǰ ½ÃÀå °³¿ä
  • Áß±¹ µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Áß±¹ µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦10Àå Àεµ µ¿¹° ÀǾàǰ ½ÃÀå

  • Àεµ µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Àεµ µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦11Àå ÀϺ» µ¿¹° ÀǾàǰ ½ÃÀå

  • ÀϺ» µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÀϺ» µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦12Àå È£ÁÖ µ¿¹° ÀǾàǰ ½ÃÀå

  • È£ÁÖ µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • È£ÁÖ µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦13Àå Àεµ³×½Ã¾Æ µ¿¹° ÀǾàǰ ½ÃÀå

  • Àεµ³×½Ã¾Æ µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Àεµ³×½Ã¾Æ µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦14Àå Çѱ¹ µ¿¹° ÀǾàǰ ½ÃÀå

  • Çѱ¹µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Çѱ¹ µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦15Àå ¼­À¯·´ µ¿¹° ÀǾàǰ ½ÃÀå

  • ¼­À¯·´ µ¿¹° ÀǾàǰ ½ÃÀå °³¿ä
  • ¼­À¯·´ µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¼­À¯·´ µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦16Àå ¿µ±¹ µ¿¹° ÀǾàǰ ½ÃÀå

  • ¿µ±¹ µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¿µ±¹ µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦17Àå µ¶ÀÏ µ¿¹° ÀǾàǰ ½ÃÀå

  • µ¶ÀÏ µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¶ÀÏ µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦18Àå ÇÁ¶û½º µ¿¹° ÀǾàǰ ½ÃÀå

  • ÇÁ¶û½º µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ÇÁ¶û½º µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦19Àå µ¿À¯·´ µ¿¹° ÀǾàǰ ½ÃÀå

  • µ¿À¯·´ µ¿¹° ÀǾàǰ ½ÃÀå °³¿ä
  • µ¿À¯·´ µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • µ¿À¯·´ µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦20Àå ·¯½Ã¾Æ µ¿¹° ÀǾàǰ ½ÃÀå

  • ·¯½Ã¾Æ µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ·¯½Ã¾Æ µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦21Àå ºÏ¹Ì µ¿¹° ÀǾàǰ ½ÃÀå

  • ºÏ¹Ì µ¿¹° ÀǾàǰ ½ÃÀå °³¿ä
  • ºÏ¹Ì µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºÏ¹Ì µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦22Àå ¹Ì±¹ µ¿¹° ÀǾàǰ ½ÃÀå

  • ¹Ì±¹ µ¿¹° ÀǾàǰ ½ÃÀå °³¿ä
  • ¹Ì±¹ µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¹Ì±¹ µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦23Àå ³²¹Ì µ¿¹° ÀǾàǰ ½ÃÀå

  • ³²¹Ì µ¿¹° ÀǾàǰ ½ÃÀå °³¿ä
  • ³²¹Ì µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ³²¹Ì µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦24Àå ºê¶óÁú µ¿¹° ÀǾàǰ ½ÃÀå

  • ºê¶óÁú µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ºê¶óÁú µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦25Àå Áßµ¿ µ¿¹° ÀǾàǰ ½ÃÀå

  • Áßµ¿ µ¿¹° ÀǾàǰ ½ÃÀå °³¿ä
  • Áßµ¿ µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • Áßµ¿ µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦26Àå ¾ÆÇÁ¸®Ä« µ¿¹° ÀǾàǰ ½ÃÀå

  • ¾ÆÇÁ¸®Ä« µ¿¹° ÀǾàǰ ½ÃÀå °³¿ä
  • ¾ÆÇÁ¸®Ä« µ¿¹° ÀǾàǰ ½ÃÀå, Á¦Ç°º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F
  • ¾ÆÇÁ¸®Ä« µ¿¹° ÀǾàǰ ½ÃÀå, ÃÖÁ¾ ¿ëµµº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2017-2022, 2022-2027F, 2032F

Á¦27Àå µ¿¹° ÀǾàǰ ½ÃÀå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • µ¿¹° ÀǾàǰ ½ÃÀå °æÀï ±¸µµ
  • µ¿¹° ÀǾàǰ ½ÃÀå ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Zoetis Inc
    • Merck &Co. Inc.
    • Elanco Animal Health Incorporated
    • Dechra Pharmaceuticals plc
    • Ceva Sante Animale

Á¦28Àå µ¿¹° ÀǾàǰ ½ÃÀåÀÇ ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦29Àå µ¿¹° ÀǾàǰ ½ÃÀåÀÇ ¹Ì·¡ÀÇ Àü¸Á°ú °¡´É¼º ºÐ¼®

Á¦30Àå ºÎ·Ï

LSH 23.05.02

“Veterinary Medicine Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary medicine? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The veterinary medicine market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Drugs; Vaccines; Medical feed additives
  • 2) By Animal Type: Companion animals; Livestock animals
  • 3) By Route of Administration: Oral route; Parental route; Topical route
  • 4) By Distribution Channel: Veterinary Hospital pharmacies; Retail veterinary pharmacies
  • 5) By End-use: Reference Laboratories; Point-of-Care Testing/In-House Testing; Veterinary Hospitals and Clinics; Other End-users
  • Companies Mentioned: Zoetis Inc.; Merck & Co. Inc.; Elanco Animal Health Incorporated; Dechra Pharmaceuticals plc; Ceva Sante Animale
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the veterinary medicine market are: Zoetis Inc., Merck & Co. Inc., Elanco Animal Health Incorporated, Dechra Pharmaceuticals plc, Ceva Sante Animale, Virbac, Boehringer Ingelheim International GmbH, Kindred Biosciences, Inc., Biogenesis Bago SA, Indian Immunologicals Limited, Neogen Corporation, Hester Biosciences Limited, Phibro Animal Health, Nutreco N.V., and Vetoquinol S.A.

The global veterinary medicine market is expected to grow from $26.94 billion in 2022 to $28.87 billion in 2023 at a compound annual growth rate (CAGR) of 7.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The veterinary medicine market is expected to grow to $37.08 billion in 2027 at a CAGR of 6.5%.

The veterinary medicine market consists of sales of dicloxacillin, erythromycin, and tetracycline, retinoids, which are naturally occurring and synthetic compounds with vitamin A activity. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Veterinary medicine refers to the field of medicine that includes the diagnosis, treatment, and prevention of ailments in animals.

North America was the largest region in the veterinary medicine market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main products of veterinary medicine are drugs, vaccines, and medical feed additives. Drugs refer to medications that are pharmacologically active chemicals, given to animals when they are ill and improve animal health and development. The animals such as companion and livestock animals are administered through oral, parental, and topical routes of administration and are distributed through various distribution channels including veterinary hospital pharmacies and retail veterinary pharmacies used by various end-users such as reference laboratories, point-of-care testing/in-house testing, veterinary hospitals and clinics, and others.

The increasing number of pet owners is expected to propel the growth of the veterinary medicine market. Pet owners are individuals who own or adopt a pet animal. Pet owners take care of their pets and their health. Thus, they provide necessary health facilities to the pets, which increases the demand for veterinary drugs and drives the veterinary medicine market. For instance, in 2021, according to a national poll by The American Society for the Prevention of Cruelty to Animals (ASPCA), a US-based non-profit organization working to prevent animal cruelty, out of all the respondents, one in five households had a cat or dog from the beginning of COVID-19 crisis which accounted for 23 million households. 90% of dogs and 85% of cats were still in their adopted houses and the households were not considering abandoning them again. As a result, the increasing number of pet owners is driving the veterinary medicine market.

Product innovation is a key trend in the veterinary medicine market forward. Major companies operating in the veterinary medicine market are introducing new products, such as Stelfonta injectables to sustain their position in the market. For instance, in July 2020, Virbac, a France-based company focused on animal health product development, launched a Stelfonta injectable to treat mast cell tumours in dogs. The new product is a breakthrough solution for mast cell tumours which is a leading form of skin cancer. Stelfonta uniquely destroys tumours without the need for surgery.

In August 2020, Elanco, a US-based pharmaceutical company, acquired Bayer Animal Health for an undisclosed amount. This acquisition will enable Elanco to solidify a direct-to-consumer strategy that focuses on the veterinarian to create new development potential that gives Elanco a chance to profit from recent trends that the COVID-19 pandemic has driven. Bayer Animal Health is a Germany-based pharmaceutical company.

The countries covered in the veterinary medicine market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The veterinary medicine market research report is one of a series of new reports from The Business Research Company that provides veterinary medicine market statistics, including veterinary medicine industry global market size, regional shares, competitors with a veterinary medicine market share, detailed veterinary medicine market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary medicine industry. This veterinary medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Veterinary Medicine Market Characteristics

3. Veterinary Medicine Market Trends And Strategies

4. Veterinary Medicine Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Veterinary Medicine Market
  • 4.2. Ukraine-Russia War Impact On Veterinary Medicine Market
  • 4.3. Impact Of High Inflation On Veterinary Medicine Market

5. Veterinary Medicine Market Size And Growth

  • 5.1. Global Veterinary Medicine Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Veterinary Medicine Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Veterinary Medicine Market Segmentation

  • 6.1. Global Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Drugs
  • Vaccines
  • Medical Feed Additives
  • 6.2. Global Veterinary Medicine Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Companion animals
  • Livestock animals
  • 6.3. Global Veterinary Medicine Market, Segmentation By Route of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Oral route
  • Parental route
  • Topical route
  • 6.4. Global Veterinary Medicine Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Veterinary Hospital pharmacies
  • Retail veterinary pharmacies
  • 6.5. Global Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Reference Laboratories
  • Point-of-Care Testing/In-House Testing
  • Veterinary Hospitals and Clinics
  • Other End-users

7. Veterinary Medicine Market Regional And Country Analysis

  • 7.1. Global Veterinary Medicine Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Veterinary Medicine Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Veterinary Medicine Market

  • 8.1. Asia-Pacific Veterinary Medicine Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Veterinary Medicine Market

  • 9.1. China Veterinary Medicine Market Overview
  • 9.2. China Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Veterinary Medicine Market

  • 10.1. India Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Veterinary Medicine Market

  • 11.1. Japan Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Veterinary Medicine Market

  • 12.1. Australia Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Veterinary Medicine Market

  • 13.1. Indonesia Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Veterinary Medicine Market

  • 14.1. South Korea Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Veterinary Medicine Market

  • 15.1. Western Europe Veterinary Medicine Market Overview
  • 15.2. Western Europe Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Veterinary Medicine Market

  • 16.1. UK Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Veterinary Medicine Market

  • 17.1. Germany Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Veterinary Medicine Market

  • 18.1. France Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Veterinary Medicine Market

  • 19.1. Eastern Europe Veterinary Medicine Market Overview
  • 19.2. Eastern Europe Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Veterinary Medicine Market

  • 20.1. Russia Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Veterinary Medicine Market

  • 21.1. North America Veterinary Medicine Market Overview
  • 21.2. North America Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Veterinary Medicine Market

  • 22.1. USA Veterinary Medicine Market Overview
  • 22.2. USA Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Veterinary Medicine Market

  • 23.1. South America Veterinary Medicine Market Overview
  • 23.2. South America Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Veterinary Medicine Market

  • 24.1. Brazil Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Veterinary Medicine Market

  • 25.1. Middle East Veterinary Medicine Market Overview
  • 25.2. Middle East Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Veterinary Medicine Market

  • 26.1. Africa Veterinary Medicine Market Overview
  • 26.2. Africa Veterinary Medicine Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Veterinary Medicine Market, Segmentation By End-use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Veterinary Medicine Market Competitive Landscape And Company Profiles

  • 27.1. Veterinary Medicine Market Competitive Landscape
  • 27.2. Veterinary Medicine Market Company Profiles
    • 27.2.1. Zoetis Inc
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Merck & Co. Inc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Elanco Animal Health Incorporated
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Dechra Pharmaceuticals plc
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Ceva Sante Animale
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Veterinary Medicine Market

29. Veterinary Medicine Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦